EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Cuting edge mastocytosis: genetics, burden, and therapeutic

Sunday 02 Jun, 16:45 PM - 18:15 PM Valencia, Spain
Bilbao Oral Abstract Sessions
16:45
The Burden of Indolent Systemic Mastocytosis in Europe: Results From the PRISM Patient Survey
16:57
A new tryptase gene haplotype in human associates alpha-triplication and beta-deletion
17:09
Idiopathic mast cell activation syndrome infrequent among patients with suspected mast cell disorders
17:21
Prevalence of drug-induced anaphylaxis low among 470 patients with mastocytosis - A two-center retrospective study
17:33
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Epicutaneous Allergen-Induced Atopic Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117
17:45
The importance of bone evaluation in patients with systemic mastocytosis
17:57
Safety of Avapritinib in Indolent Systemic Mastocytosis (ISM): Longer Term Follow-up From the PIONEER Study

Speakers